EDQM launches Know-X database

Published: 1-Apr-2014
Regulatory

A user-friendly tool for regulators working to reduce counterfeit medical products


The European Directorate for the Quality of Medicines (EDQM) has launched the Know-X database to assist regulators in the fight against counterfeit/falsified medical products.

The database collates reports on counterfeit/falsified medical products that have been detected in Council of Europe member states.

EDQM says this user-friendly tool will allow officials to expand their knowledge and awareness of counterfeit/falsified medicines, provide a basis for the exchange of information, highlight and encourage collaboration between health and law enforcement authorities, and foster the sharing of analytical information on the testing of counterfeit/falsified and other illegal medicines within the Network of Official Medicines Control Laboratories (OMCLs).

The database contains details on closed cases of counterfeit/falsified medical products, technical information on the testing performed, the authorities involved and what actions were taken. The information is gathered from various sources (e.g. OMCLs, health authorities, regulatory agencies, medical products surveillance authorities, customs and police) and it is intended to provide governments with decision aids for the management and prevention of specific risks.

Access to the database can be requested by officials working for: a competent health or law enforcement authority in a Council of Europe member state or in a state party to the MEDICRIME Convention that is directly involved in fighting counterfeit/falsified medical products and similar crimes, or a member of the European OMCL Network that does not belong to the core testing group.

  • Companies:
  • European Directorate Quality Medicine
See more

You may also like

Regulatory

Europe releases 10th Pharmacopoeia edition with 114 new monographs

Read more
Thoroughly revised general chapters include infrared absorption spectrophotometry and Ultraviolet & visible absorption spectrophotometry

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  2. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Europe releases 10th Pharmacopoeia edition with 114 new monographs

Thoroughly revised general chapters include infrared absorption spectrophotometry and Ultraviolet & visible absorption spectrophotometry
Regulatory

Maintaining high quality standards in a dynamic global environment

Dr Susanne Keitel, Director of the EDQM, explains how the Ph. Eur. continues to meet the challenges of today’s global environment
Regulatory

European Pharmacopoeia (Ph. Eur.) Commission adopts new monographs and makes a number of revisions

They will come into effect in July 2017
Regulatory

OMCL Network meets higher demand for independent experimental testing through enhanced work-sharing and collaboration

Most of the MRP/DCP products tested in 2015 were generic drugs
Regulatory

EDQM publishes guidance on strategy to counter medicrime

Says aligned and close co-operation among authorities and stakeholders is key to fighting counterfeiting and similar crimes
Regulatory

EDQM renews its ISO 9001:2008 certification

And extends its scope to pharmacopoeial activities
Regulatory

Accelerating and enhancing toxicology assessments

Infographic guides users through ToxHQ’s speedy assessment features
Subscribe now